Fr. 57.50

Changing the Paradigm of Aldosterone Diagnosis by 61Co Labeling

English · Paperback / Softback

Shipping usually within 1 to 2 weeks (title will be printed to order)

Description

Read more

This book is aimed at all those interested in exploring new methods for diagnosing adrenal insufficiency, particularly in the current context of the COVID-19 pandemic. Adrenal insufficiency is a complex medical condition that requires accurate diagnosis for effective treatment. Current diagnostic methods, while useful, have certain limitations. This book presents a promising new method for diagnosing adrenal insufficiency, involving the use of 61Cobalt-labeled eplerenone and MRI.In the context of the COVID-19 pandemic, this method could prove particularly useful, as the virus can affect blood pressure regulation and potentially cause conditions such as hypertension or hypotension.We hope this book will be a valuable resource for those seeking to improve the diagnosis and treatment of adrenal insufficiency.

About the author










Dr. Abdelhafid Mimouni, 56, holds a PhD in Bioinorganic Systems Chemistry from the University of Paris XII - Créteil in 1997. He also holds an advanced diploma in bioinorganic systems from the University of Paris XI - Orsay, obtained in 1993, and a bachelor's and master's degree in chemistry in 1991-1992 from the same university.

Product details

Authors Abdelhafid Mimouni
Publisher Our Knowledge Publishing
 
Languages English
Product format Paperback / Softback
Released 15.02.2024
 
EAN 9786207170197
ISBN 9786207170197
No. of pages 56
Subjects Natural sciences, medicine, IT, technology > Chemistry
Non-fiction book > Nature, technology > Natural science

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.